Skip to main content
Screener/Healthcare/Biotechnology

DNTH — Dianthus Therapeutics, Inc.

NASDAQ
$95.01-3.34 (-3.40%)
Mid CapHealthcareLow Beta
$32.22
$117.88
$95.01
$98.53
EPS (TTM)$-0.11
P/E Ratio112.19
Dividend Yield—
Market Cap$5.86B
Volume60K
Prev Close$98.35
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$40.8M$-0.85——
Q4 '25$284K$97.9M$2.59100.0%34473.6%
Q3 '25$396K-$36.8M$-0.97100.0%-9284.1%
Q2 '25$193K-$31.6M$-0.88100.0%-16388.1%
Q1 '25$1.2M-$29.5M$-0.82100.0%-2537.5%
Q4 '24$1.3M-$28.4M$-0.81100.0%-2144.8%
Q3 '24$2.2M-$25.2M$-0.74100.0%-1159.0%
Q2 '24$1.9M-$17.6M$-0.51100.0%-945.1%
Get Your Daily Market Recap